CTI Granted US Patent; Patient Examination Bed for Breast Cancer Detection System Receives Patent Protection.

Business Editors/Health &Medical Writers

LAYTON, Utah--(BUSINESS WIRE)--Jan. 27, 2000

Computerized Thermal Imaging, Inc. (CTI--OTC Symbol COII) announced today that it has been granted a US patent for its unique patient examination bed. The bed is a critical part of CTI's breast cancer detection system currently in clinical trials in five hospitals across the country.

&uot;I am pleased that patent protection has been granted for this portion of our breast cancer system,&uot; stated David Packer, President. &uot;Our patient examination bed is the critical element in our system that ensures consistent high quality images. This patent recognizes the innovative nature of our developments. It is the result of an aggressive intellectual property protection program.&uot;

CTI is seeking FDA approval for use of its breast imaging system as an adjunct to mammography. The system uses a sophisticated heat sensitive digital camera to record images of the heat produced by breast tissue. These images are then processed by a proprietary computer program that is designed to recognize the distinct heat signatures of malignant and benign breast tumors. Nearly 80% of the 750,000 breast biopsies performed in the US each year turn out benign. Consequently, hundreds of thousands of women are undergoing unneeded pain, stress and expense. The goal of CTI is to improve the quality of life for women by reducing benign biopsies. Its non-invasive test takes approximately four minutes and is simple, painless and involves no radiation, breast compression, electrodes or electrical current. CTI recently received FDA approval for the first of five modular submissions leading to FDA Premarket Approval.

Computerized Thermal Imaging, Inc. is in business to improve quality of life through the development and deployment of thermal imaging and associated technologies. More information about CTI can be found on the Internet at www.cti-net.com or by calling CTI Public Affairs at [phone].

Except for historical information contained herein, the matters discussed in this news release are forward-looking statements that involve risks and uncertainties. The forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. In addition to the factors set forth above, other important factors that could cause actual results to differ materially include, but are not limited to technical risks associated with new technology development, government regulatory approvals or continued working capital. Additional information concerning factors that could cause actual results to differ materially from those in the forward-looking statements is contained from time to time in the Company's SEC filings. Copies of these filings may be obtained by contacting the Company or the SEC.